Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00742261 · ClinicalTrials.gov registry record · Phase 1
A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00742261 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 12 participants.
The verdict
NCT00742261, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
Study to compare 2 different chemical forms of GSK1363089.
Interventions
- DRUG GSK1363089
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-08-11 |
| Est. Completion | 2009-06-24 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00742261
The ClinicalTrials.gov registry entry for NCT00742261 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GSK1363089 is the first listed.
NCT00742261 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00742261 about?
NCT00742261 is a clinical study titled "A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors". Study to compare 2 different chemical forms of GSK1363089.
What is the current status of trial NCT00742261?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2008-08-11. Estimated completion is 2009-06-24.
What interventions are being tested in trial NCT00742261?
The interventions under investigation include: GSK1363089 (DRUG).
Who is sponsoring clinical trial NCT00742261?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.